ArticleMultiple sclerosis journal - experimental, translational and clinical
Factors affecting MS patients' health-related quality of life and measurement challenges in Lebanon and the MENA region.
Article in Multiple sclerosis journal - experimental, translational and clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 24 citations in OpenAlex.
- Cultural Adaptation and Validation of the CALMS Questionnaire in an Arabic-Speaking MS Population.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026Article
- Quality of life among patients with multiple sclerosis: association with disease acceptance, optimism, and health-promoting behaviors.Scientific reports · 2025Article
- Quality of life and access to treatment for patients with multiple sclerosis during economic crisis: the Lebanese experience.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025Article
- Sociodemographic and Clinical Determinants of the Quality of Life of Moroccan People With Multiple Sclerosis.International journal of MS care · 2025Article
- Effect of a Therapeutic Patient Education Program on the Quality of Life of People With Multiple Sclerosis: A Quasi-Experimental Study.International journal of MS care · 2025Article
- Impact of Cognitive Impairment on Quality of Life in Multiple Sclerosis Patients-A Comprehensive Review.Journal of clinical medicine · 2024Review
- Experiences of persons with multiple sclerosis of a collaborative care programme: A qualitative study.Nursing open · 2023Article
- The effect of applying the nursing process based on the Theory of Goal Attainment on activities of daily living and quality of life in persons with multiple sclerosis during COVID-19 pandemic: a clinical trial.Irish journal of medical science · 2023Article
- Patient's perspective in clinical practice to assess and predict disability in multiple sclerosis.Scientific reports · 2022Observational
- Identifying the Psychometric Properties of the Malay Version of the WHOQOL-BREF among Employees with Obesity Problem.International journal of environmental research and public health · 2022Article
- The quality of life in patients with multiple sclerosis - Association with depressive symptoms and physical disability: A prospective and observational study.Frontiers in psychology · 2022Article
- Fatigue, Physical Disability and Self-Efficacy as Predictors of the Acceptance of Illness and Health-Related Quality of Life in Patients with Multiple Sclerosis.International journal of environmental research and public health · 2021Article
- The Role of Stress Perception and Coping with Stress and the Quality of Life Among Multiple Sclerosis Patients.Psychology research and behavior management · 2021Article
- A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous InterferonMultiple sclerosis international · 2021Article
- Multiple sclerosis in the Middle East and North Africa region.Multiple sclerosis journal - experimental, translational and clinicalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn the Middle East and North Africa (MENA) region, few studies explored the quality of life of multiple sclerosis patients and the factors affecting it.
objectiveThe objective of this study was to explore studies on multiple sclerosis quality of life in the MENA area through a comprehensive literature review. To validate the Multiple sclerosis international Quality of Life (MusiQoL) and Modified Fatigue Impact Scale (MFIS) in Arabic, and investigate the impact of sociodemographic and clinical variables of Lebanese multiple sclerosis patients on quality of life.
methodsAs part of an ongoing observational prospective research study, data from 663 stable multiple sclerosis patients were analysed.
resultsIn Lebanese multiple sclerosis patients, the Arabic MusiQoL and MFIS seem to be accurate and valid tools with high reliability coefficients and confirmatory factor analytic indices. Variables such as age and disease type predicted multiple sclerosis quality of life, yet were significantly affected by psychosocial fatigue. The influence of sociodemographic and clinical variables on quality of life dimensions varied. Being a woman with multiple sclerosis, receiving medications and experiencing physical fatigue worsens the psychological wellbeing quality of life dimension.
conclusionSeveral sociodemographic and clinical variables predicted the health-related quality of life dimensions of multiple sclerosis patients in MENA. Further in-depth investigation to guide more targeted clinical management is recommended. We encourage using validated multidimensional tools to measure quality of life in MENA such as the Arabic MusiQoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.